STOCK TITAN

Cabaletta Bio: Bain fund reports 9.57% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Cabaletta Bio, Inc. (CABA) shareholder Bain Capital Life Sciences Opportunities III, L.P. reported holding 15,209,188 common shares and a pre-funded warrant to purchase up to 6,000,000 additional shares as of September 30, 2026. The reported aggregate beneficial ownership was 21,209,188 shares, or 9.57%, with shared voting and dispositive power over that amount.

The 9.57% calculation used 215,720,392 CABA shares outstanding as of October 30, 2026, plus the 6,000,000 shares issuable under the warrant. The warrant cannot be exercised if doing so would cause the holder to beneficially own more than 9.99% of the shares then issued and outstanding immediately after exercise.

Common shares held 15,209,188 shares Held by Bain Capital Life Sciences Opportunities III, L.P. as of September 30, 2026
Pre-funded warrant Up to 6,000,000 shares Shares purchasable under the warrant held as of September 30, 2026
Aggregate beneficial ownership 21,209,188 shares Reported by Bain Capital Life Sciences Opportunities III, L.P.
Percent of class 9.57% Reported ownership percentage
Beneficial-ownership limit 9.99% Maximum resulting ownership permitted for warrant exercise under the stated restriction
CABA shares outstanding 215,720,392 shares As of October 30, 2026; used in the reported ownership-percentage calculation
pre-funded warrant financial
"a pre-funded warrant to purchase up to 6,000,000 shares"
A pre-funded warrant is a financial instrument that gives the holder the right to buy shares of a company's stock at a set price, with most of the purchase cost already paid upfront. It functions like a nearly fully paid option, allowing investors to secure shares quickly while minimizing the amount of additional money they need to invest later. This helps investors gain ownership rights efficiently, often used to avoid certain regulatory restrictions or to prepare for future stock purchases.
beneficially own regulatory
"beneficially own more than 9.99% of the total number of shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
shared voting power regulatory
"Shared Voting Power 21,209,188.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 21,209,188.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CABA shares did Bain Capital Life Sciences Opportunities III report?

It reported holding 15,209,188 common shares and a pre-funded warrant to purchase up to 6,000,000 shares. Its reported aggregate beneficial ownership was 21,209,188 shares, or 9.57%.

What restriction applies to the CABA pre-funded warrant?

The holder cannot exercise the warrant if the exercise would cause it to beneficially own more than 9.99% of CABA’s shares issued and outstanding immediately after exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





12674W109

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Bain Capital Life Sciences Opportunities III, LP
Signature:/s/ Andrew Hack
Name/Title:Andrew Hack, Partner of Bain Capital Life Sciences Investors, LLC
Date:11/16/2026

Keep reading